Loadingβ¦
Loadingβ¦
MicroLink Devices (founded 2000, Niles, Illinois) grows III-V compound-semiconductor epitaxial wafers by MOCVD on 4- and 6-inch GaAs and InP substrates.
Another tracked dossier names this company as a counterparty in its own sourced disclosure β this platform never wrote these rows on this company's own page, they are read here inverted from the dossier that disclosed them. This is a partial view: 995 additional named-counterparty rows across the corpus could not be matched to a tracked dossier by name at all (mostly non-Latin legal names), so the true count is higher than what renders here.
Epitaxial-liftoff (ELO) multijunction gallium-arsenide solar sheets for the Zephyr S high-altitude pseudo-satellite (HAPS) platform β the only named-supplier lead found this tick for the gallium exposure (top-scored material, 95). MicroLink's own announcement, redistributed by pv magazine/SpaceRef rather than posted by Airbus, hence confidence: secondary. Two ageing factors: (1) the announcement is a decade old and no renewal or successor contract was found; (2) the Zephyr business unit was carved out of Airbus Defence and Space into AALTO HAPS from 2022-2023 β AALTO is not itself onboarded as a subsidiary dossier in this corpus, and Airbus retains majority (not 100%) ownership per a 2024-06 Japanese-consortium $100m investment (NTT DOCOMO/Space Compass), so this row documents a real but structurally-displaced and unreconfirmed relationship, not a current Airbus SE procurement line.
Scope. This section is inverted evidence: each linked dossier wrote the original row about itself, describing its own relationship to this company. It is never a claim this company itself disclosed. Absence here is not evidence of no relationship β most of the corpus has no named-counterparty block at all yet.
Every exposure is read as a buyer dependency; the top 2 are its binding chokepoints.
As a buyer, policy pressure across its consumed materials is flat.
Descriptive trend in official policy actions on this companyβs materials β a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.
No actions in the register have named or swept this company in the last 24 months.